T lymphocytes engineered to produce T cell receptors specific for tumor antigens lead to an antitumor immune response. New findings draw attention to a potentially deadly problem with this strategy. The transgenic T cell receptors can shuffle components with native receptors to produce hybrid molecules with specificity against self antigens (pages 565–570).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
07 June 2010
In the version of this News and Views initially published, the last name of one of the authors whose work was being discussed, Gavin M. Bendle, was incorrectly written as ‘Bender’ in three places. The error has been corrected in the HTML and PDF versions of the article.
References
Bendle, G.M. et al. 16, 565–570 (2010).
Rosenberg, S.A., Restifo, N.P., Yang, J.C., Morgan, R.A. & Dudley, M.E. Nat. Rev. Cancer 8, 299–308 (2008).
Bollard, C.M. et al. Blood 110, 2838–2845 (2007).
Hunder, N.N. et al. N. Engl. J. Med. 358, 2698–2703 (2008).
Morgan, R.A. et al. Science 314, 126–129 (2006).
Kuball, J. et al. Blood 109, 2331–2338 (2007).
Okamoto, S. et al. Cancer Res. 69, 9003–9011 (2009).
Stewart-Jones, G. et al. Proc. Natl. Acad. Sci. USA 106, 5784–5788 (2009).
Ciceri, F. et al. Lancet Oncol. 10, 489–500 (2009).
Tey, S.K., Dotti, G., Rooney, C.M., Heslop, H.E. & Brenner, M.K. Biol. Blood Marrow Transplant. 13, 913–924 (2007).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Brenner, M. T cell receptors and cancer: gain gives pain. Nat Med 16, 520–521 (2010). https://doi.org/10.1038/nm0510-520
Issue Date:
DOI: https://doi.org/10.1038/nm0510-520
This article is cited by
-
An MHC-restricted antibody-based chimeric antigen receptor requires TCR-like affinity to maintain antigen specificity
Molecular Therapy - Oncolytics (2016)